Paper832345
Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201.
Pohost GM and 5 others. Circulation, 1977. Cited by 632 papers, by iCite.
Cite this record
ConductScience Library. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Papers, record 832345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/832345
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Myocardial Infarction | Major topic |
| Radionuclide Imaging | Major topic |
| Thallium | Major topic |
| Acute Disease | |
| Adult | |
| Aged | |
| Angina Pectoris | |
| Animals | |
| Coronary Circulation | |
| Diagnosis, Differential | |
| Dogs | |
| Exercise Test | |
| Humans | |
| Middle Aged |
Source PubMed
Cited by104
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 632 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42684519 | The Return of Thallium-201 for American Patients: History, Radiopharmaceutical Features, and Current Applications. | Curr Cardiol Rep | 2026 | https://conductscience.org/library/papers/42684519 | PubMed |
| 39788340 | The complex role of cardiovascular imaging in viability testing. | Prog Cardiovasc Dis | 2025 | https://conductscience.org/library/papers/39788340 | PubMed |
| 34944803 | New Radionuclides and Technological Advances in SPECT and PET Scanners. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34944803 | PubMed |
| 33415645 | Interpretation and clinical management of patients with "Fixed" myocardial perfusion defects : A call for quantifying endocardial-to-epicardial distribution of blood flow. | J Nucl Cardiol | 2021 | https://conductscience.org/library/papers/33415645 | PubMed |
| 32367225 | George A. Beller, MD (Born 1940). | J Nucl Cardiol | 2020 | https://conductscience.org/library/papers/32367225 | PubMed |
| 24598955 | Twenty four hour imaging delay improves viability detection by Tl-201 myocardial perfusion scintigraphy. | Rev Bras Cir Cardiovasc | 2013 | https://conductscience.org/library/papers/24598955 | PubMed |
| 24380041 | Comparative evaluation of the diagnostic accuracy of (99m)Tc-sestamibi gated SPECT using five different sets of image acquisitions at stress and rest phases for the diagnosis of coronary artery disease. | Am J Nucl Med Mol Imaging | 2013 | https://conductscience.org/library/papers/24380041 | PubMed |
| 24146698 | Reverse perfusion pattern in myocardial spect with 99mTc-sestaMIBI. | J Med Life | 2013 | https://conductscience.org/library/papers/24146698 | PubMed |
| 23539330 | Crown years for non-invasive cardiovascular imaging (Part II): 40 years of nuclear cardiology. | Neth Heart J | 2013 | https://conductscience.org/library/papers/23539330 | PubMed |
| 23296470 | Fifty years of progress in radionuclide assessment of myocardial perfusion. | J Nucl Cardiol | 2013 | https://conductscience.org/library/papers/23296470 | PubMed |
| 21732226 | SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability. | J Cardiovasc Transl Res | 2011 | https://conductscience.org/library/papers/21732226 | PubMed |
| 20821132 | New protocol of myocardial SPECT imaging with technetium-99m sestamibi for reducing the time interval between rest and adenosine stress phases. | Radiol Phys Technol | 2009 | https://conductscience.org/library/papers/20821132 | PubMed |
| 20186583 | The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. | J Nucl Cardiol | 2010 | https://conductscience.org/library/papers/20186583 | PubMed |
| 19408065 | Assessment of myocardial perfusion with Tc-99m: image is everything. | J Nucl Cardiol | 2009 | https://conductscience.org/library/papers/19408065 | PubMed |
| 19356479 | Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. | JACC Cardiovasc Imaging | 2008 | https://conductscience.org/library/papers/19356479 | PubMed |
| 16084434 | Assessment of myocardial viability using F-18 fluorodeoxyglucose/Tc-99m sestamibi dual-isotope simultaneous acquisition SPECT: comparison with Tl-201 stress-reinjection SPECT. | J Nucl Cardiol | 2005 | https://conductscience.org/library/papers/16084434 | PubMed |
| 15173779 | The historical and conceptual evolution of radionuclide assessment of myocardial viability. | J Nucl Cardiol | 2004 | https://conductscience.org/library/papers/15173779 | PubMed |
| 14752475 | Myocardial perfusion imaging agents: SPECT and PET. | J Nucl Cardiol | 2004 | https://conductscience.org/library/papers/14752475 | PubMed |
| 12032482 | Quantification of SPECT myocardial perfusion imaging. | J Nucl Cardiol | 2002 | https://conductscience.org/library/papers/12032482 | PubMed |
| 12025953 | The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction. | Int J Cardiovasc Imaging | 2001 | https://conductscience.org/library/papers/12025953 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/832345
GET https://conductscience.org/api/papers/v1/832345/cited_by?page=2